SCHEMBL927520

SCHEMBL927520

O=C(CC(O)C(=O)O)Oc1ccccc1Oc1ccccc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
GAA P10253 5/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
JAK2 O60674 2/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
SERPINE1 P05121 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
ESR1 P03372 1/20 0.35
ALOX15 P16050 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ESR2 Q92731 1/20 0.35
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL689242 0.78 GAA (0.44) HSD17B10KDM4EALDH1A1HPGDGAA
SCHEMBL4570542 0.77 ALOX15 (0.38) KDM4EALDH1A1HPGDGAASMN1; SMN2
SCHEMBL928340 0.76 KDM4E (0.46) THRATHRBHSD17B10KDM4EALDH1A1
SCHEMBL926703 0.75 KDM4E (0.44) THRATHRBKDM4EALDH1A1SMN1; SMN2
SCHEMBL927217 0.75 KDM4E (0.44) THRATHRBKDM4EALDH1A1SMN1; SMN2
SCHEMBL927685 0.75 GAA (0.38) THRATHRBHSD17B10KDM4EALDH1A1
SCHEMBL10813524 0.72 GAA (0.50) ALDH1A1HPGDGAASMN1; SMN2JAK2
SCHEMBL7806601 0.72 CA2 (0.59) HSD17B10KDM4EALDH1A1HPGDGAA
SCHEMBL5813451 0.72 PTGS2 (0.52) HSD17B10KDM4EALDH1A1HPGDGAA
SCHEMBL27521080 0.71 TDP1 (0.47) HSD17B10KDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222446-B2 Method for producing dihydroxybenzene derivative MITSUI CHEMICALS, INC. (JP) 2012-07-17 US disclosed
US-20110004013-A1 METHOD FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE MITSUI CHEMICALS, INC. (JP) 2011-01-06 US disclosed
EP-2269976-A1 PROCESS FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE Mitsui Chemicals, Inc. (JP) 2011-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004013-A1 METHOD FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE UBE2B, UBE2G2, TUBB2B THRA 1626/4885THRB 829/4885HSD17B10 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.